{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T03:36:37Z","timestamp":1787283397752,"version":"build-2736575974"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T00:00:00Z","timestamp":1579651200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T00:00:00Z","timestamp":1579651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["18K09018"],"award-info":[{"award-number":["18K09018"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["19H03676"],"award-info":[{"award-number":["19H03676"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00223-020-00659-6","type":"journal-article","created":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T02:02:34Z","timestamp":1579658554000},"page":"104-115","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Congenital Hyperphosphatemic Conditions Caused by the Deficient Activity of FGF23"],"prefix":"10.1007","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4071-5372","authenticated-orcid":false,"given":"Nobuaki","family":"Ito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Fukumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,22]]},"reference":[{"issue":"9","key":"659_CR1","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1007\/s00198-018-4574-x","volume":"29","author":"M Chakhtoura","year":"2018","unstructured":"Chakhtoura M et al (2018) Hyperphosphatemic familial tumoral calcinosis secondary to fibroblast growth factor 23 (FGF23) mutation: a report of two affected families and review of the literature. Osteoporos Int 29(9):1987\u20132009","journal-title":"Osteoporos Int"},{"issue":"4","key":"659_CR2","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.beem.2012.01.004","volume":"26","author":"H Al-Azem","year":"2012","unstructured":"Al-Azem H, Khan AA (2012) Hypoparathyroidism. Best Pract Res Clin Endocrinol Metab 26(4):517\u2013522","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"659_CR3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1172\/JCI118038","volume":"96","author":"R Kilav","year":"1995","unstructured":"Kilav R, Silver J, Naveh-Many T (1995) Parathyroid hormone gene expression in hypophosphatemic rats. J Clin Invest 96(1):327\u2013333","journal-title":"J Clin Invest"},{"issue":"11","key":"659_CR4","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1172\/JCI118701","volume":"97","author":"E Slatopolsky","year":"1996","unstructured":"Slatopolsky E et al (1996) Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest 97(11):2534\u20132540","journal-title":"J Clin Invest"},{"issue":"4","key":"659_CR5","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1073\/pnas.95.4.1909","volume":"95","author":"MF Pfister","year":"1998","unstructured":"Pfister MF et al (1998) Parathyroid hormone leads to the lysosomal degradation of the renal type II Na\/Pi cotransporter. Proc Natl Acad Sci USA 95(4):1909\u20131914","journal-title":"Proc Natl Acad Sci USA"},{"key":"659_CR6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/978-1-4614-0887-1_3","volume":"728","author":"C Bergwitz","year":"2012","unstructured":"Bergwitz C, J\u00fcppner H (2012) FGF23 and syndromes of abnormal renal phosphate handling. Adv Exp Med Biol 728:41\u201364","journal-title":"Adv Exp Med Biol"},{"key":"659_CR7","unstructured":"Ramnitz MS, Gafni RI, Collins MT (2018) Hyperphosphatemic familial tumoral calcinosis. GeneReviews\u00ae [Internet]. University of Washington, Seattle, Seattle, WA , pp 1993\u20132019"},{"issue":"10167","key":"659_CR8","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0140-6736(18)33045-9","volume":"393","author":"V Tiwari","year":"2012","unstructured":"Tiwari V et al (2019) Hyperphosphataemic tumoral calcinosis. Lancet 12;393(10167):168","journal-title":"Lancet"},{"issue":"8","key":"659_CR9","doi-asserted-by":"publisher","first-page":"3179","DOI":"10.1210\/endo.143.8.8795","volume":"143","author":"T Shimada","year":"2002","unstructured":"Shimada T et al (2002) Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo. Endocrinology 143(8):3179\u20133182","journal-title":"Endocrinology"},{"issue":"3","key":"659_CR10","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1359\/JBMR.0301264","volume":"19","author":"T Shimada","year":"2004","unstructured":"Shimada T et al (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19(3):429\u2013435","journal-title":"J Bone Miner Res"},{"issue":"12","key":"659_CR11","first-page":"4003","volume":"117","author":"IZ Ben-Dov","year":"2007","unstructured":"Ben-Dov IZ et al (2007) The parathyroid is a target organ for FGF23 in rats. J Clin Invest 117(12):4003\u20134008","journal-title":"J Clin Invest"},{"issue":"5831","key":"659_CR12","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1126\/science.1135901","volume":"316","author":"A Imura","year":"2007","unstructured":"Imura A et al (2007) alpha-Klotho as a regulator of calcium homeostasis. Science 316(5831):1615\u20131618","journal-title":"Science"},{"key":"659_CR13","doi-asserted-by":"publisher","first-page":"40534","DOI":"10.1038\/srep40534","volume":"7","author":"K Kawakami","year":"2017","unstructured":"Kawakami K et al (2017) Persistent fibroblast growth factor 23 signalling in the parathyroid glands for secondary hyperparathyroidism in mice with chronic kidney disease. Sci Rep 7:40534","journal-title":"Sci Rep"},{"issue":"10","key":"659_CR14","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1359\/jbmr.090406","volume":"24","author":"SM Burnett-Bowie","year":"2009","unstructured":"Burnett-Bowie SM et al (2009) Effects of hPTH(1\u201334) infusion on circulating serum phosphate, 1,25-dihydroxyvitamin D, and FGF23 levels in healthy men. J Bone Miner Res 24(10):1681\u20131685","journal-title":"J Bone Miner Res"},{"issue":"10","key":"659_CR15","doi-asserted-by":"publisher","first-page":"5523","DOI":"10.1210\/jc.2005-0301","volume":"90","author":"K Araya","year":"2005","unstructured":"Araya K et al (2005) A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis. J Clin Endocrinol Metab 90(10):5523\u20135527","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"659_CR16","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1093\/hmg\/ddi034","volume":"14","author":"A Benet-Pag\u00e8s","year":"2005","unstructured":"Benet-Pag\u00e8s A et al (2005) An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. Hum Mol Genet 14(3):385\u2013390","journal-title":"Hum Mol Genet"},{"issue":"6","key":"659_CR17","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/ng1358","volume":"36","author":"O Topaz","year":"2004","unstructured":"Topaz O et al (2004) Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis. Nat Genet 36(6):579\u2013581","journal-title":"Nat Genet"},{"issue":"9","key":"659_CR18","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1172\/JCI31330","volume":"117","author":"S Ichikawa","year":"2007","unstructured":"Ichikawa S et al (2007) A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis. J Clin Invest 117(9):2684\u20132691","journal-title":"J Clin Invest"},{"issue":"8","key":"659_CR19","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00402-004-0715-0","volume":"124","author":"EP Polykandriotis","year":"2004","unstructured":"Polykandriotis EP et al (2004) A case of familial tumoral calcinosis in a neonate and review of the literature. Arch Orthop Trauma Surg 124(8):563\u2013567","journal-title":"Arch Orthop Trauma Surg"},{"issue":"10","key":"659_CR20","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1002\/jbmr.2870","volume":"31","author":"MS Ramnitz","year":"2016","unstructured":"Ramnitz MS et al (2016) Phenotypic and genotypic characterization and treatment of a cohort with familial tumoral calcinosis\/hyperostosis-hyperphosphatemia syndrome. J Bone Miner Res 31(10):1845\u20131854","journal-title":"J Bone Miner Res"},{"issue":"7120","key":"659_CR21","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/nature05315","volume":"444","author":"I Urakawa","year":"2006","unstructured":"Urakawa I et al (2006) Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444(7120):770\u2013774","journal-title":"Nature"},{"issue":"10","key":"659_CR22","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1002\/jbmr.478","volume":"26","author":"S W\u00f6hrle","year":"2011","unstructured":"W\u00f6hrle S et al (2011) FGF receptors control vitamin D and phosphate homeostasis by mediating renal FGF-23 signaling and regulating FGF-23 expression in bone. J Bone Miner Res 26(10):2486\u20132497","journal-title":"J Bone Miner Res"},{"issue":"4","key":"659_CR23","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/jbmr.1810","volume":"28","author":"S W\u00f6hrle","year":"2013","unstructured":"W\u00f6hrle S et al (2013) Pharmacological inhibition of fibroblast growth factor (FGF) receptor signaling ameliorates FGF23-mediated hypophosphatemic rickets. J Bone Miner Res 28(4):899\u2013911","journal-title":"J Bone Miner Res"},{"issue":"2","key":"659_CR24","doi-asserted-by":"publisher","first-page":"e57322","DOI":"10.1371\/journal.pone.0057322","volume":"8","author":"AL Wu","year":"2013","unstructured":"Wu AL et al (2013) Antibody-mediated activation of FGFR1 induces FGF23 production and hypophosphatemia. PLoS ONE 8(2):e57322","journal-title":"PLoS ONE"},{"issue":"4","key":"659_CR25","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/path.4465","volume":"235","author":"JC Lee","year":"2015","unstructured":"Lee JC et al (2015) Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour. J Pathol 235(4):539\u2013545","journal-title":"J Pathol"},{"issue":"23","key":"659_CR26","doi-asserted-by":"publisher","first-page":"11418","DOI":"10.1073\/pnas.1815166116","volume":"116","author":"Y Takashi","year":"2019","unstructured":"Takashi Y et al (2019) Activation of unliganded FGF receptor by extracellular phosphate potentiates proteolytic protection of FGF23 by its O-glycosylation. Proc Natl Acad Sci USA 116(23):11418\u201311427","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"659_CR27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1359\/jbmr.061105","volume":"22","author":"Y Frishberg","year":"2007","unstructured":"Frishberg Y et al (2007) Hyperostosis-hyperphosphatemia syndrome: a congenital disorder of O-glycosylation associated with augmented processing of fibroblast growth factor 23. J Bone Miner Res 22(2):235\u2013242","journal-title":"J Bone Miner Res"},{"issue":"8","key":"659_CR28","doi-asserted-by":"publisher","first-page":"e104154","DOI":"10.1371\/journal.pone.0104154","volume":"9","author":"Z Xiao","year":"2014","unstructured":"Xiao Z et al (2014) Osteocyte-specific deletion of Fgfr1 suppresses FGF23. PLoS ONE 9(8):e104154","journal-title":"PLoS ONE"},{"issue":"11","key":"659_CR29","doi-asserted-by":"publisher","first-page":"4267","DOI":"10.1210\/jc.2009-0961","volume":"94","author":"C Bergwitz","year":"2009","unstructured":"Bergwitz C et al (2009) Defective O-glycosylation due to a novel homozygous S129P mutation is associated with lack of fibroblast growth factor 23 secretion and tumoral calcinosis. J Clin Endocrinol Metab 94(11):4267\u20134274","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"659_CR30","doi-asserted-by":"publisher","first-page":"5368","DOI":"10.1172\/JCI122004","volume":"128","author":"MS Roberts","year":"2018","unstructured":"Roberts MS et al (2018) Autoimmune hyperphosphatemic tumoral calcinosis in a patient with FGF23 autoantibodies. J Clin Invest 128(12):5368\u20135373","journal-title":"J Clin Invest"},{"issue":"283","key":"659_CR31","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1093\/qjmed\/77.2.1175","volume":"77","author":"P Nichols","year":"1990","unstructured":"Nichols P et al (1990) Parathyroidectomy in chronic renal failure: a nine-year follow-up study. Q J Med 77(283):1175\u20131193","journal-title":"Q J Med"},{"issue":"1","key":"659_CR32","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000169078","volume":"17","author":"B Pecovnik-Balon","year":"1997","unstructured":"Pecovnik-Balon B, Kramberger S (1997) Tumoral calcinosis in patients on hemodialysis. Case report and review of the literature. Am J Nephrol 17(1):93\u201395","journal-title":"Am J Nephrol"},{"issue":"6","key":"659_CR33","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/sj.jid.5701203","volume":"128","author":"I Chefetz","year":"2008","unstructured":"Chefetz I et al (2008) Normophosphatemic familial tumoral calcinosis is caused by deleterious mutations in SAMD9, encoding a TNF-alpha responsive protein. J Invest Dermatol 128(6):1423\u20131429","journal-title":"J Invest Dermatol"},{"key":"659_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-019-01097-4","author":"QY Zuo","year":"2019","unstructured":"Zuo QY et al (2019) Clinical and genetic analysis of idiopathic normophosphatemic tumoral calcinosis in 19 patients. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-019-01097-4","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"659_CR35","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1136\/bjsm.32.4.287","volume":"32","author":"JB King","year":"1998","unstructured":"King JB (1998) Post-traumatic ectopic calcification in the muscles of athletes: a review. Br J Sports Med 32(4):287\u2013290","journal-title":"Br J Sports Med"},{"issue":"4","key":"659_CR36","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1172\/JCI200419081","volume":"113","author":"T Shimada","year":"2004","unstructured":"Shimada T et al (2004) Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 113(4):561\u2013568","journal-title":"J Clin Invest"},{"issue":"7","key":"659_CR37","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.matbio.2004.09.007","volume":"23","author":"D Sitara","year":"2004","unstructured":"Sitara D et al (2004) Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. Matrix Biol 23(7):421\u2013432","journal-title":"Matrix Biol"},{"issue":"6","key":"659_CR38","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1210\/en.2008-0877","volume":"150","author":"S Ichikawa","year":"2009","unstructured":"Ichikawa S et al (2009) Ablation of the Galnt3 gene leads to low-circulating intact fibroblast growth factor 23 (Fgf23) concentrations and hyperphosphatemia despite increased Fgf23 expression. Endocrinology 150(6):2543\u20132550","journal-title":"Endocrinology"},{"issue":"6655","key":"659_CR39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/36285","volume":"390","author":"M Kuro-o","year":"1997","unstructured":"Kuro-o M et al (1997) Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390(6655):45\u201351","journal-title":"Nature"},{"issue":"1","key":"659_CR40","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1148\/radiology.174.1.2294551","volume":"174","author":"S Martinez","year":"1990","unstructured":"Martinez S et al (1990) Imaging of tumoral calcinosis: new observations. Radiology 174(1):215\u2013222","journal-title":"Radiology"},{"issue":"3","key":"659_CR41","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1148\/rg.263055099","volume":"26","author":"KM Olsen","year":"2006","unstructured":"Olsen KM, Chew FS (2006) Tumoral calcinosis: pearls, polemics, and alternative possibilities. Radiographics 26(3):871\u2013885","journal-title":"Radiographics"},{"issue":"11","key":"659_CR42","doi-asserted-by":"publisher","first-page":"4472","DOI":"10.1210\/jc.2006-1247","volume":"91","author":"S Ichikawa","year":"2006","unstructured":"Ichikawa S et al (2006) Tumoral calcinosis presenting with eyelid calcifications due to novel missense mutations in the glycosyl transferase domain of the GALNT3 gene. J Clin Endocrinol Metab 91(11):4472\u20134475","journal-title":"J Clin Endocrinol Metab"},{"key":"659_CR43","first-page":"2010","volume":"20","author":"E McGrath","year":"2010","unstructured":"McGrath E, Harney F, Kinsella F (2010) An ocular presentation of familial tumoral calcinosis. BMJ Case Rep 20:2010","journal-title":"BMJ Case Rep"},{"issue":"5","key":"659_CR44","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00774-011-0260-1","volume":"29","author":"A Yancovitch","year":"2011","unstructured":"Yancovitch A et al (2011) Novel mutations in GALNT3 causing hyperphosphatemic familial tumoral calcinosis. J Bone Miner Metab 29(5):621\u2013625","journal-title":"J Bone Miner Metab"},{"key":"659_CR45","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12863-014-0098-3","volume":"15","author":"S Rafaelsen","year":"2014","unstructured":"Rafaelsen S et al (2014) Long-term clinical outcome and phenotypic variability in hyperphosphatemic familial tumoral calcinosis and hyperphosphatemic hyperostosis syndrome caused by a novel GALNT3 mutation; case report and review of the literature. BMC Genet 15:98","journal-title":"BMC Genet"},{"issue":"12","key":"659_CR46","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1093\/ndt\/gfu324","volume":"29","author":"A Shah","year":"2014","unstructured":"Shah A et al (2014) Severe vascular calcification and tumoral calcinosis in a family with hyperphosphatemia: a fibroblast growth factor 23 mutation identified by exome sequencing. Nephrol Dial Transplant 29(12):2235\u20132243","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"659_CR47","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s00198-008-0775-z","volume":"20","author":"CE Dumitrescu","year":"2009","unstructured":"Dumitrescu CE et al (2009) A case of familial tumoral calcinosis\/hyperostosis-hyperphosphatemia syndrome due to a compound heterozygous mutation in GALNT3 demonstrating new phenotypic features. Osteoporos Int 20(7):1273\u20131278","journal-title":"Osteoporos Int"},{"issue":"11","key":"659_CR48","doi-asserted-by":"publisher","first-page":"6001","DOI":"10.1073\/pnas.100041297","volume":"97","author":"F Ringpfeil","year":"2000","unstructured":"Ringpfeil F et al (2000) Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter. Proc Natl Acad Sci USA 97(11):6001\u20136006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"659_CR49","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1136\/jcp.2005.026369","volume":"59","author":"MF Campagnoli","year":"2006","unstructured":"Campagnoli MF et al (2006) Familial tumoral calcinosis and testicular microlithiasis associated with a new mutation of GALNT3 in a white family. J Clin Pathol 59(4):440\u2013442","journal-title":"J Clin Pathol"},{"issue":"20","key":"659_CR50","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1002\/ajmg.a.31947","volume":"143A","author":"HJ Garringer","year":"2007","unstructured":"Garringer HJ et al (2007) Two novel GALNT3 mutations in familial tumoral calcinosis. Am J Med Genet A 143A(20):2390\u20132396","journal-title":"Am J Med Genet A"},{"issue":"2","key":"659_CR51","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00439-005-0026-8","volume":"118","author":"I Chefetz","year":"2005","unstructured":"Chefetz I et al (2005) A novel homozygous missense mutation in FGF23 causes Familial Tumoral Calcinosis associated with disseminated visceral calcification. Hum Genet 118(2):261\u2013266","journal-title":"Hum Genet"},{"issue":"4","key":"659_CR52","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1210\/jc.2004-2238","volume":"90","author":"T Larsson","year":"2005","unstructured":"Larsson T et al (2005) A novel recessive mutation in fibroblast growth factor-23 causes familial tumoral calcinosis. J Clin Endocrinol Metab 90(4):2424\u20132427","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"659_CR53","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1210\/jc.2006-1825","volume":"92","author":"S Ichikawa","year":"2007","unstructured":"Ichikawa S et al (2007) Novel GALNT3 mutations causing hyperostosis-hyperphosphatemia syndrome result in low intact fibroblast growth factor 23 concentrations. J Clin Endocrinol Metab 92(5):1943\u20131947","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"659_CR54","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/S0022-3476(81)80013-3","volume":"99","author":"MA Mikati","year":"1981","unstructured":"Mikati MA, Melhem RE, Najjar SS (1981) The syndrome of hyperostosis and hyperphosphatemia. J Pediatr 99(6):900\u2013904","journal-title":"J Pediatr"},{"issue":"4","key":"659_CR55","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/ajmg.a.33337","volume":"152A","author":"S Ichikawa","year":"2010","unstructured":"Ichikawa S et al (2010) Clinical variability of familial tumoral calcinosis caused by novel GALNT3 mutations. Am J Med Genet A 152A(4):896\u2013903","journal-title":"Am J Med Genet A"},{"issue":"3","key":"659_CR56","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1159\/000197876","volume":"71","author":"JJ Lammoglia","year":"2009","unstructured":"Lammoglia JJ, Mericq V (2009) Familial tumoral calcinosis caused by a novel FGF23 mutation: response to induction of tubular renal acidosis with acetazolamide and the non-calcium phosphate binder sevelamer. Horm Res 71(3):178\u2013184","journal-title":"Horm Res"},{"issue":"5","key":"659_CR57","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1177\/1066896912444925","volume":"20","author":"RE Slavin","year":"2012","unstructured":"Slavin RE, Wen J, Barmada A (2012) Tumoral calcinosis\u2014a pathogenetic overview: a histological and ultrastructural study with a report of two new cases, one in infancy. Int J Surg Pathol 20(5):462\u2013473","journal-title":"Int J Surg Pathol"},{"issue":"4","key":"659_CR58","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1086\/508069","volume":"79","author":"O Topaz","year":"2006","unstructured":"Topaz O et al (2006) A deleterious mutation in SAMD9 causes normophosphatemic familial tumoral calcinosis. Am J Hum Genet 79(4):759\u2013764","journal-title":"Am J Hum Genet"},{"issue":"37","key":"659_CR59","doi-asserted-by":"publisher","first-page":"23976","DOI":"10.1074\/jbc.273.37.23976","volume":"273","author":"DR Warner","year":"1998","unstructured":"Warner DR et al (1998) A novel mutation in the switch 3 region of Gsalpha in a patient with Albright hereditary osteodystrophy impairs GDP binding and receptor activation. J Biol Chem 273(37):23976\u201323983","journal-title":"J Biol Chem"},{"issue":"5","key":"659_CR60","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/ng1783","volume":"38","author":"EM Shore","year":"2006","unstructured":"Shore EM et al (2006) A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet 38(5):525\u2013527","journal-title":"Nat Genet"},{"issue":"4","key":"659_CR61","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.ajhg.2013.08.007","volume":"93","author":"O Eytan","year":"2013","unstructured":"Eytan O et al (2013) Cole disease results from mutations in ENPP1. Am J Hum Genet 93(4):752\u2013757","journal-title":"Am J Hum Genet"},{"issue":"20","key":"659_CR62","doi-asserted-by":"publisher","first-page":"7666","DOI":"10.1073\/pnas.85.20.7666","volume":"85","author":"MJ Weiss","year":"1988","unstructured":"Weiss MJ et al (1988) A missense mutation in the human liver\/bone\/kidney alkaline phosphatase gene causing a lethal form of hypophosphatasia. Proc Natl Acad Sci USA 85(20):7666\u20137669","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"659_CR63","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1136\/ard.48.7.571","volume":"48","author":"AJ Chuck","year":"1989","unstructured":"Chuck AJ et al (1989) Crystal deposition in hypophosphatasia: a reappraisal. Ann Rheum Dis 48(7):571\u2013576","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"659_CR64","doi-asserted-by":"publisher","first-page":"223","DOI":"10.4103\/JCAS.JCAS_78_17","volume":"10","author":"S Tandon","year":"2017","unstructured":"Tandon S et al (2017) Multiple asymptomatic juxta-articular nodules mimicking tuberous-xanthoma-a unusual presentation of tophaceous gout. J Cutan Aesthet Surg 10(4):223\u2013225","journal-title":"J Cutan Aesthet Surg"},{"issue":"1","key":"659_CR65","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1111\/j.1365-4632.2012.05508.x","volume":"53","author":"AD Maderal","year":"2014","unstructured":"Maderal AD, Viera MH, Alonso-Llamazares J (2014) Systemic lupus erythematosus with dystrophic calcifications. Int J Dermatol 53(1):e74\u201375","journal-title":"Int J Dermatol"},{"issue":"5","key":"659_CR66","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s10067-014-2696-x","volume":"35","author":"T Nakamura","year":"2016","unstructured":"Nakamura T et al (2016) Dystrophic calcinosis with both a huge calcified mass in the cervical spine and calcification in the chest wall in a patient with rheumatoid overlap syndrome. Clin Rheumatol 35(5):1403\u20131409","journal-title":"Clin Rheumatol"},{"issue":"2","key":"659_CR67","first-page":"55","volume":"52","author":"A Dima","year":"2014","unstructured":"Dima A, Balanescu P, Baicus C (2014) Pharmacological treatment in calcinosis cutis associated with connective-tissue diseases. Rom J Intern Med 52(2):55\u201367","journal-title":"Rom J Intern Med"},{"issue":"4","key":"659_CR68","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/jcu.22097","volume":"42","author":"TK Kim","year":"2014","unstructured":"Kim TK et al (2014) Synovial osteochondromatosis in the subacromial bursa mimicking calcific tendinitis: sonographic diagnosis. J Clin Ultrasound 42(4):237\u2013240","journal-title":"J Clin Ultrasound"},{"issue":"1046","key":"659_CR69","doi-asserted-by":"publisher","first-page":"20140608","DOI":"10.1259\/bjr.20140608","volume":"88","author":"AD Baheti","year":"2015","unstructured":"Baheti AD et al (2015) Imaging features of primary and metastatic extremity synovial sarcoma: a single institute experience of 78 patients. Br J Radiol 88(1046):20140608","journal-title":"Br J Radiol"},{"issue":"4","key":"659_CR70","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1210\/jcem-50-4-648","volume":"50","author":"EG Lufkin","year":"1980","unstructured":"Lufkin EG et al (1980) Phosphorus excretion in tumoral calcinosis: response to parathyroid hormone and acetazolamide. J Clin Endocrinol Metab 50(4):648\u2013653","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"659_CR71","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1002\/ajmg.a.36476","volume":"164A","author":"G Finer","year":"2014","unstructured":"Finer G et al (2014) Hyperphosphatemic familial tumoral calcinosis: response to acetazolamide and postulated mechanisms. Am J Med Genet A 164A(6):1545\u20131549","journal-title":"Am J Med Genet A"},{"issue":"4 Suppl","key":"659_CR72","doi-asserted-by":"publisher","first-page":"247S","DOI":"10.1016\/8756-3282(95)00019-A","volume":"16","author":"T Yamaguchi","year":"1995","unstructured":"Yamaguchi T et al (1995) Successful treatment of hyperphosphatemic tumoral calcinosis with long-term acetazolamide. Bone 16(4 Suppl):247S\u2013250S","journal-title":"Bone"},{"issue":"10","key":"659_CR73","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1210\/jc.2006-0305","volume":"91","author":"HJ Garringer","year":"2006","unstructured":"Garringer HJ et al (2006) The role of mutant UDP-N-acetyl-alpha-D-galactosamine-polypeptide N-acetylgalactosaminyltransferase 3 in regulating serum intact fibroblast growth factor 23 and matrix extracellular phosphoglycoprotein in heritable tumoral calcinosis. J Clin Endocrinol Metab 91(10):4037\u20134042","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"659_CR74","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00109-015-1331-x","volume":"94","author":"CB Leibrock","year":"2016","unstructured":"Leibrock CB et al (2016) Acetazolamide sensitive tissue calcification and aging of klotho-hypomorphic mice. J Mol Med (Berl) 94(1):95\u2013106","journal-title":"J Mol Med (Berl)"},{"key":"659_CR75","doi-asserted-by":"publisher","first-page":"569","DOI":"10.12659\/AJCR.892113","volume":"15","author":"G Favia","year":"2014","unstructured":"Favia G et al (2014) Hyperphosphatemic familial tumoral calcinosis: odontostomatologic management and pathological features. Am J Case Rep 15:569\u2013575","journal-title":"Am J Case Rep"},{"issue":"7","key":"659_CR76","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1210\/jc.2016-1087","volume":"101","author":"J Jost","year":"2016","unstructured":"Jost J et al (2016) Topical sodium thiosulfate: a treatment for calcifications in hyperphosphatemic familial tumoral calcinosis? J Clin Endocrinol Metab 101(7):2810\u20132815","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-020-00659-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-020-00659-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-020-00659-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T00:38:14Z","timestamp":1611189494000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-020-00659-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,22]]},"references-count":76,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["659"],"URL":"https:\/\/doi.org\/10.1007\/s00223-020-00659-6","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,22]]},"assertion":[{"value":"29 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}